Loading...
Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy
BACKGROUND: Hearing loss is common following chemoradiotherapy for children with medulloblastoma. Compared to photons, proton radiotherapy reduces radiation dose to the cochlea for these patients. Here we examine whether this dosimetric advantage leads to a clinical benefit in audiometric outcomes....
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3123575/ https://ncbi.nlm.nih.gov/pubmed/21635776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-6-58 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|